Search

Search Constraints

You searched for: Author/Creator Ren, Liangliang

Search Results

2. Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. Issue 12 (28th October 2019)

3. Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. Issue 12 (28th October 2019)

4. Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. Issue 3 (7th March 2022)

5. Exosome‐derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase‐3‐dependent cleavage. Issue 1 (3rd January 2023)

6. Hyaluronan‐mediated motility receptor confers resistance to chemotherapy via TGFβ/Smad2‐induced epithelial‐mesenchymal transition in gastric cancer. Issue 5 (25th February 2019)

8. Overexpression of CDCA7 predicts poor prognosis and induces EZH2‐mediated progression of triple‐negative breast cancer. Issue 10 (19th September 2018)

9. RNF219/α‐Catenin/LGALS3 Axis Promotes Hepatocellular Carcinoma Bone Metastasis and Associated Skeletal Complications. Issue 16 (18th August 2021)

10. RNF219/α‐Catenin/LGALS3 Axis Promotes Hepatocellular Carcinoma Bone Metastasis and Associated Skeletal Complications. Issue 4 (31st December 2020)